Publication | Open Access

Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial

VaccinationPreventive MedicineTreatment And PreventionCovid-19 Pandemic8-Month PeriodClinical TrialsAntiviral TherapySingle DosePlacebo-controlled TrialPharmacotherapyCovid-19 EpidemiologyMedicineCovid-19